Bone density recovers quickly after stopping PrEP
Tenofovir treatment raises the risk of broken bones
START sub-study shows more bone loss with earlier HIV treatment
Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety
Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis
Bone loss slows, but continues long-term in HIV-positive people on antiretroviral therapy
Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health
